ABVC BioPharma, Inc. (ECOC) Gross margin 2019–2025
ABVC BioPharma, Inc. (ECOC) gross margin by fiscal year — reported gross profit divided by reported revenue.
171.9%FY2025 · since FY2019: -25.4% → 171.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 171.9% | +201.3 pp |
| FY2024 | -29.4% | -477.7 pp |
| FY2023 | 448.3% | +412.2 pp |
| FY2022 | 36.2% | -94.3 pp |
| FY2021 | 130.5% | -10.6 pp |
| FY2020 | 141.1% | +166.5 pp |
| FY2019 | -25.4% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice